Fabry disease in hemodialysis patients in Southern Brazil: Prevalence study and clinical report

Renal Failure

Volumn 30, Issue 9, 2008, Pages 825-830

  Porsch, Daiana Benck ^a   Nunes, Ane Cláudia Fernandes ^b,c   Milani, Vagner ^a   Rossato, Liana Bertolin ^a   Mattos, Cristiane Bastos ^a   Tsao, Marilyn ^d   Netto, Cristina ^d   Burin, Maira ^d   Pereira, Fernanda ^d   Matte, Úrsula ^a,d   Giugliani, Roberto ^a,d   Barros, Elvino José Guardão ^a,d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

gal A activity; End stage renal disease; Fabry disease; Hemodialysis; Inherited nephropathy; Lysosomal storage disorder

Indexed keywords

ALPHA GALACTOSIDASE;

ANHIDROSIS; ARTICLE; ENZYME ACTIVITY; FABRY DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEMANGIOKERATOMA; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING;

ADULT; AGED; BRAZIL; CROSS-SECTIONAL STUDIES; FABRY DISEASE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PEDIGREE; PREVALENCE; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 54249123119     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802353777     Document Type: Article

References (23)

1. Desnick R, Ioannou Y, Eng C. a-Galactosidase a deficiency: Fabry disease. In: Scriver CR, Sly WS, Beaudet AL, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001:3733-3734.
2. Sachdev B, Takenaka T, Teraguchi T, et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation. 2002;105:1407-1411.
3. Rolfs A, Böttcher T, Zschiesche M, et al. Prevalence of Fabry disease in patients with cryptogenic stroke: A prospective study. Lancet. 2005;366:1794-1796.
4. Warnock D. Fabry disease: Diagnosis and management, with emphasis on the renal manifestations. Cur Opin Nephrol Hypertens. 2005;14:87-95.
5. Desnick RJ, et al. Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003;138(4):338-346.
6. Clarke JT, Knaack J, Crawhall JC, Wolfe LS. Ceramide trihexosidosis (Fabry's disease) without skin lesions. N Engl J Med. 1971;284(5):233-235.
7. Nakao S, Takenaka T, Maeda M, et al. An atypical variant of Fabry disease in men with left ventricular hypertrophy. N Engl J Med. 1995;333:288-293.
8. Desnick RJ, Brady RO. Fabry disease in childhood. J Pediatr, 2004;144(5 Suppl.): S20-S26.
9. Meroni M, Sessa A, Battini G, Tazzari S, Torri Tarelli L. Kidney involvement in Anderson-Fabry disease. Contrib Nephrol. 1997;122:178-84.
10. Nakao S, Kodama C, Takenaka T, et al. Fabry disease: Detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype. Kidney Int. 2003;64(3):801-807.
11. Linthorst GE, Hollak CE, Korevaar JC, et al. Alpha-galactosidase A deficiency in Dutch patients on dialysis: A critical appraisal of screening for Fabry disease. Nephrol Dial Transplant. 2003;18:1581-1584.
12. Meikle PJ, Hopwood JJ, Clague AE, et al. Prevalence of lysosomal storage disorders. JAMA. 1999;281(3):249-254.
13. Kotanko P, Kramar R, Devrnja D, et al. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol. 2004;15:1323-1329.
14. Thadhani R, Wolf M, West ML, et al. Patients with Fabry disease on dialysis in the United States. Kidney Int. 2002;61(1):249-255.
15. Nunes ACF, Delgado V, Porsch DB, et al. Fabry disease and hemodialysis: Determining a procedure for blood collecting on a Brazilian screening. Book of Abstracts. Rio de Janeiro, Brazil: World Congress of Nephrology; 2007: 279.
16. Chamoles NA, Blanco M, Gaggioli D. Fabry disease: enzymatic diagnosis in dried blood spots on filter paper. Clin Chim Acta. 2001;308(1-2):195-196.
17. Morgan SH, Rudge P, Smith SJ, et al. The neurological complications of Anderson-Fabry disease (alpha-Galactosidase A deficiency): Investigation of symptomatic and presymptomatic patients. Q J Med. 1990;75:491-507.
18. Grünfeld J-P. How to improve the early diagnosis of Fabry disease? Kidney Int. 2003;64:1136-1137.
19. Biagini G, Pecoits RRPF, and Weber HHMW. Prevalence of Fabry disease in patients with chronic renal insufficiency undergoing hemodialysis in the State of Paraná - Brazil. Book of Abstracts. Rio de Janeiro, Brazil: World Congress of Nephrology; 2007: 386.
20. Delgado V, Nunes ACF, Canuto M, et al. Fabry disease epidemiology in Rio de Janeiro State: Partial outcome of screening in patients on dialysis treatment. Book of Abstracts. Rio de Janeiro, Brazil: World Congress of Nephrology; 2007: 280.
21. Tumialán C, Carvalho C, Chavez R., et al. Prevalence in Peru of Fabry disease among males with chronic renal insufficiency. Book of Abstracts. San Jose, Costa Rica: X Latin American Symposium in Lysosomal Storage Disease; 2005: 191.
22. Martínez JA, Ardila ME, Gamarra G, at al. Prevalence of Fabry disease in Colombia - preliminary report. Book of Abstracts. San Jose, Costa Rica: X Latin American Symposium in Lysosomal Storage Disease; 2005: 237.
23. Ichinose M, Nakayama M, Ohashi T, et al. Significance of screening for Fabry disease among male dialysis patients. Clin Exp Nephrol. 2005;9:228-232.